Founded in 2022, Forty51 Ventures is a venture capital investment firm based in Basel, Switzerland. The firm prefers to build and invest in early-stage biotech companies across Europe.
Mosanna Therapeutics is a biotechnology company based in Basel, focused on enhancing patient outcomes and quality of life for individuals with high unmet medical needs. The company employs a precision medicine approach, specializing in the development of medicinal nasal sprays. Mosanna selects innovative medicines for further development in collaboration with leading contract research organizations, ensuring that hospitals and healthcare providers have access to effective treatment options for patients suffering from various diseases. Through its targeted efforts, Mosanna aims to address significant healthcare challenges and improve therapeutic options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.